Global Aerrane Market Research Report 2022
Aerrane(Isoflurane), sold under the trade name Forane among others, is a general anesthetic. It can be used to start or maintain anesthesia.
Due to the COVID-19 pandemic, the global Aerrane market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Aerrane market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Aerrane landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Below 100ml accounting for % of the Aerrane global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Aerrane include Baxter, AbbVie, Halocarbon, Piramal Critical Care, Aesica Queenborough, Abbott Laboratories, Toronto Research Chemicals, Abcam and VetOne, etc. In terms of revenue, the global 3 largest players have a % market share of Aerrane in 2021.
This report focuses on Aerrane volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Aerrane market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Aerrane Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Below 100ml
100-250ml
Above 250ml
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Baxter
AbbVie
Halocarbon
Piramal Critical Care
Aesica Queenborough
Abbott Laboratories
Toronto Research Chemicals
Abcam
VetOne
MedKoo Biosciences
JD Medical
Lunan Pharmaceutical
Due to the COVID-19 pandemic, the global Aerrane market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Aerrane market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Aerrane landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Below 100ml accounting for % of the Aerrane global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Aerrane include Baxter, AbbVie, Halocarbon, Piramal Critical Care, Aesica Queenborough, Abbott Laboratories, Toronto Research Chemicals, Abcam and VetOne, etc. In terms of revenue, the global 3 largest players have a % market share of Aerrane in 2021.
This report focuses on Aerrane volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Aerrane market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Aerrane Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Below 100ml
100-250ml
Above 250ml
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Baxter
AbbVie
Halocarbon
Piramal Critical Care
Aesica Queenborough
Abbott Laboratories
Toronto Research Chemicals
Abcam
VetOne
MedKoo Biosciences
JD Medical
Lunan Pharmaceutical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
